SCHEMBL14075677

SCHEMBL14075677

CC(C)(C)Oc1ccc2c(c1)OCCO2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 8/20 0.49
▸ MAOA P21397 6/20 0.49
▸ TRPV1 Q8NER1 1/20 0.46
▸ TSHR P16473 1/20 0.45
▸ PKM P14618 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ PKLR P30613 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ BLM P54132 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2733818 0.89 ALDH1A1 (0.51) MAOBMAOAMAPTNPC1TP53
SCHEMBL745193 0.78 PKM (0.54) MAOBMAOATSHRPKMMAPT
SCHEMBL30627606 0.78 PKM (0.54) MAOBMAOATSHRPKMMAPT
SCHEMBL16470745 0.74 MAOB (0.53) MAOBMAOATSHRPKMMAPT
SCHEMBL16470744 0.74 MAOB (0.53) MAOBMAOATSHRPKMMAPT
SCHEMBL2090955 0.74 MAOB (0.53) MAOBMAOATSHRPKMMAPT
SCHEMBL14088714 0.73 MAOB (0.62) MAOBMAOATSHRMAPTNPC1
SCHEMBL15982325 0.73 MAPT (0.53) MAOBMAOAPKMMAPTNPC1
SCHEMBL14964120 0.73 MAPT (0.53) MAOBMAOAPKMMAPTNPC1
SCHEMBL15982627 0.73 MAPT (0.53) MAOBMAOAPKMMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214541-A1 COMPOSITIONS AND METHODS FOR INDUCING OSTEOGENESIS IRM LLC (BM) 2008-09-04 — — US disclosed
US-7273864-B2 Compositions and methods for inducing osteogenesis THE SCRIPPS RESEARCH INSTITUTE (US) 2007-09-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214541-A1 COMPOSITIONS AND METHODS FOR INDUCING OSTEOGENESIS BMP2, BMP4, BMP6 MAOB 4744/4885MAOA 4640/4885TRPV1 4729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback